These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Synthesis and preliminary studies of O-(2-[18F] fluoroethyl)-L-tyrosine as a positron emission tomography imaging agent]. Dang YH; Wang SZ; Cheng X; Zhou Q Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):370-2. PubMed ID: 12905655 [TBL] [Abstract][Full Text] [Related]
24. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors. Pauleit D; Floeth F; Tellmann L; Hamacher K; Hautzel H; Müller HW; Coenen HH; Langen KJ J Nucl Med; 2004 Mar; 45(3):374-81. PubMed ID: 15001676 [TBL] [Abstract][Full Text] [Related]
25. Pilot Evaluation of S-(3-[ Betts HM; Luckett JC; Hill PJ Mol Imaging Biol; 2024 Aug; 26(4):704-713. PubMed ID: 38942967 [TBL] [Abstract][Full Text] [Related]
26. Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET. Ikotun OF; Marquez BV; Huang C; Masuko K; Daiji M; Masuko T; McConathy J; Lapi SE PLoS One; 2013; 8(10):e77476. PubMed ID: 24143237 [TBL] [Abstract][Full Text] [Related]
27. 2-[ Verhoeven J; Baguet T; Piron S; Pauwelyn G; Bouckaert C; Descamps B; Raedt R; Vanhove C; De Vos F; Goethals I Nucl Med Biol; 2020; 82-83():9-16. PubMed ID: 31841816 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of O-(3-[18F]fluoropropyl)-L-tyrosine as an oncologic PET tracer. Tang G; Wang M; Tang X; Luo L; Gan M Nucl Med Biol; 2003 Oct; 30(7):733-9. PubMed ID: 14499331 [TBL] [Abstract][Full Text] [Related]
30. First-in-human assessment of the novel LAT1 targeting PET probe Nozaki S; Nakatani Y; Mawatari A; Hume WE; Wada Y; Ishii A; Tanaka M; Tsuyuguchi N; Doi H; Watanabe Y Biochem Biophys Res Commun; 2022 Mar; 596():83-87. PubMed ID: 35121373 [TBL] [Abstract][Full Text] [Related]
31. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. Heiss P; Mayer S; Herz M; Wester HJ; Schwaiger M; Senekowitsch-Schmidtke R J Nucl Med; 1999 Aug; 40(8):1367-73. PubMed ID: 10450690 [TBL] [Abstract][Full Text] [Related]
33. Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[ Langen KJ; Stoffels G; Filss C; Heinzel A; Stegmayr C; Lohmann P; Willuweit A; Neumaier B; Mottaghy FM; Galldiks N Methods; 2017 Nov; 130():124-134. PubMed ID: 28552264 [TBL] [Abstract][Full Text] [Related]
34. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas. Israel I; Brandau W; Farmakis G; Samnick S Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046 [TBL] [Abstract][Full Text] [Related]
35. Influence of Bevacizumab on Blood-Brain Barrier Permeability and Stegmayr C; Oliveira D; Niemietz N; Willuweit A; Lohmann P; Galldiks N; Shah NJ; Ermert J; Langen KJ J Nucl Med; 2017 May; 58(5):700-705. PubMed ID: 28153956 [TBL] [Abstract][Full Text] [Related]
36. Spatial heterogeneity of low-grade gliomas at the capillary level: a PET study on tumor blood flow and amino acid uptake. Wyss MT; Hofer S; Hefti M; Bärtschi E; Uhlmann C; Treyer V; Roelcke U J Nucl Med; 2007 Jul; 48(7):1047-52. PubMed ID: 17574979 [TBL] [Abstract][Full Text] [Related]
37. Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. Spaeth N; Wyss MT; Weber B; Scheidegger S; Lutz A; Verwey J; Radovanovic I; Pahnke J; Wild D; Westera G; Weishaupt D; Hermann DM; Kaser-Hotz B; Aguzzi A; Buck A J Nucl Med; 2004 Nov; 45(11):1931-8. PubMed ID: 15534065 [TBL] [Abstract][Full Text] [Related]